PTC Therapeutics Inc (NASDAQ: PTCT) kicked off on Tuesday, up 3.22% from the previous trading day, before settling in for the closing price of $43.84. Over the past 52 weeks, PTCT has traded in a range of $23.58-$54.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 32.36% over the last five years. While this was happening, its average annual earnings per share was recorded 46.00%. With a float of $75.41 million, this company’s outstanding shares have now reached $76.95 million.
The firm has a total of 995 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.59%, operating margin of -14.47%, and the pretax margin is -47.24%.
PTC Therapeutics Inc (PTCT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of PTC Therapeutics Inc is 2.23%, while institutional ownership is 101.67%. The most recent insider transaction that took place on Jan 08 ’25, was worth 73,959. In this transaction SVP, CHIEF ACCOUNTING OFFICER of this company sold 1,662 shares at a rate of $44.50, taking the stock ownership to the 64,321 shares. Before that another transaction happened on Jan 07 ’25, when Company’s SVP, CHIEF ACCOUNTING OFFICER sold 1,291 for $45.34, making the entire transaction worth $58,534. This insider now owns 65,983 shares in total.
PTC Therapeutics Inc (PTCT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.00% per share during the next fiscal year.
PTC Therapeutics Inc (NASDAQ: PTCT) Trading Performance Indicators
Take a look at PTC Therapeutics Inc’s (PTCT) current performance indicators. Last quarter, stock had a quick ratio of 2.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.94, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of PTC Therapeutics Inc (PTCT)
Analysing the last 5-days average volume posted by the [PTC Therapeutics Inc, PTCT], we can find that recorded value of 0.73 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 49.58%. Additionally, its Average True Range was 2.15.
During the past 100 days, PTC Therapeutics Inc’s (PTCT) raw stochastic average was set at 62.48%, which indicates a significant decrease from 66.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.41% in the past 14 days, which was lower than the 56.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.16, while its 200-day Moving Average is $36.84. Now, the first resistance to watch is $46.03. This is followed by the second major resistance level at $46.81. The third major resistance level sits at $48.34. If the price goes on to break the first support level at $43.72, it is likely to go to the next support level at $42.19. Should the price break the second support level, the third support level stands at $41.41.
PTC Therapeutics Inc (NASDAQ: PTCT) Key Stats
The company with the Market Capitalisation of 3.49 billion has total of 77,125K Shares Outstanding. Its annual sales at the moment are 937,820 K in contrast with the sum of -626,600 K annual income. Company’s last quarter sales were recorded 196,790 K and last quarter income was -106,650 K.
